Mesenchymal Stem Cell Therapy Shows Promising Results in COVID-19 Treatment

A groundbreaking mesenchymal stem cell (MSC) therapy has demonstrated significant survival benefits for critically ill COVID-19 patients. An Israeli company reported successful treatment of its first COVID-19 patient under the country’s compassionate use program. The company’s findings showed that six critically ill patients, all at high mortality risk, received treatment with human mesenchymal stem cells […]